Case Report
Accepted on 28 Mar 2025
Teclistamab in the treatment of idiopathic immune thrombocytopenia in patients with multiple myeloma
in Immunobiology and Immunotherapy
Frontiers in Hematology
doi 10.3389/frhem.2025.1547209
Type at least 3 characters
127 articles
Articles
Review
Accepted on 26 Mar 2025
Metabolic Reprogramming of Fetal Hematopoietic Stem and Progenitor Cells by Maternal Obesity
in Hematopoiesis and Stem Cells
Frontiers in Hematology
doi 10.3389/frhem.2025.1575143
Clinical Trial
Accepted on 21 Mar 2025
Preliminary clinical activity of TP-0903 in relapsed or refractory acute myeloid leukemia with FLT3-ITD mutations
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1554764
Review
Published on 21 Mar 2025
Exercise and diet studies among patients living with multiple myeloma: current evidence and considerations of patient preferences
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1550681
- 619 views
Original Research
Published on 21 Mar 2025
Cochrane’s contribution to global health: three decades of progress in sickle cell disease research
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1535100
- 199 views
Brief Research Report
Accepted on 18 Mar 2025
Assessing Maternal and Perinatal Complication Incidence in Pregnant Patients with Sickle Cell Disease: A Retrospective Analysis of Transfusion Therapy at a Tertiary Care Hospital
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1549241
Original Research
Accepted on 17 Mar 2025
Anemia and its predictors among neonates at Wachemo University Teaching Hospital, Central Ethiopia. A Facility based cross-sectional study
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1550664
Original Research
Published on 17 Mar 2025
HPLC first approach in detecting thalassemia and other common hemoglobinopathies is more cost and time effective
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1461498
- 426 views
Case Report
Published on 04 Mar 2025
Case Report: Triplet combination with pirtobrutinib/venetoclax/rituximab in accelerated phase of chronic lymphocytic leukemia
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1552200
- 491 views
Editorial
Published on 04 Mar 2025
Editorial: Hematopoietic stress in stem cell homeostasis and disease pathogenesis
in Hematopoiesis and Stem Cells
Frontiers in Hematology
doi 10.3389/frhem.2025.1571674
- 273 views
Review
Published on 03 Mar 2025
Abnormalities of primary and secondary hemostasis in multiple myeloma: insights from studies on thrombopoiesis, the coagulation system, and the bone marrow microenvironment
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1435193
- 525 views
Original Research
Published on 27 Feb 2025
FACIT-Fatigue scale in patients with cold agglutinin disease: psychometric validation and estimation of clinically meaningful change
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1490130
- 308 views
Case Report
Published on 26 Feb 2025
Acquired von Willebrand disease associated with smoldering multiple myeloma and hereditary hemorrhagic telangiectasia successfully treated with daratumumab, pomalidomide, and dexamethasone: hitting three birds with one stone? – case report
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1499500
- 373 views
Mini Review
Published on 26 Feb 2025
The role of glucocorticoids in erythropoiesis
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1540152
- 404 views
Original Research
Published on 21 Feb 2025
Time to initiation of antiresorptive agents in multiple myeloma to reduce skeletal related events
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1521017
- 270 views
Mini Review
Published on 07 Feb 2025
The aging hematopoietic stem cell niche: a mini review
in Hematopoiesis and Stem Cells
Frontiers in Hematology
doi 10.3389/frhem.2025.1525132
- 528 views